Clinical Trials on Sickle Cell Disease (SCD) in Switzerland
Total 790 results
-
Novartis PharmaceuticalsCompleted
-
IpsenTerminatedGastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic TumoursUnited States, France, Belgium, Switzerland, Netherlands
-
Basilea PharmaceuticaCompleted
-
ETOP IBCSG Partners FoundationAstraZenecaRecruitingImmunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (CHESS)Non-small Cell Lung Cancer | Oligometastasis | Stage IVSwitzerland, Netherlands, Spain, Italy
-
OnxeoCompletedMelanomaAustria, France, Germany, Switzerland
-
ETOP IBCSG Partners FoundationCompleted
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingNon-small Cell Lung Cancer | Malignant Pleural MesotheliomaSwitzerland
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedLymphomaFrance, Spain, Italy, Belgium, Germany, Switzerland, Austria, United Kingdom, Netherlands, Sweden
-
International Extranodal Lymphoma Study Group (IELSG)CompletedPrimary Mediastinal B-Cell LymphomaItaly, United Kingdom, Switzerland, Spain
-
IpsenTerminatedSmall Cell Lung Cancer and Breast CancerUnited States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
-
CureVacTerminatedNon-Small Cell Lung CarcinomaGermany, Switzerland, Austria
-
Institut CurieServier; UNICANCERCompletedUveal MelanomaFrance, Switzerland
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingSmall Cell Lung Cancer | Lung CancerSwitzerland
-
ImmunoGen, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic LeukemiaUnited States, Switzerland
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
Bristol-Myers SquibbEuropean Organisation for Research and Treatment of Cancer - EORTCTerminatedGlioblastomaSwitzerland, Netherlands, Italy, France
-
Anaveon AGRecruitingLung Cancer | Advanced Solid Tumor | Adult DiseaseUnited Kingdom, Switzerland, Spain
-
IpsenActive, not recruitingNeuroendocrine TumorsAustria, Denmark, Switzerland, Australia, United Kingdom, France
-
AmgenRecruitingSmall-Cell Lung Cancer | Extensive-Stage Small-Cell Lung CancerUnited States, China, Japan, Switzerland, Turkey
-
Hoffmann-La RocheCompletedGlioblastoma MultiformeSwitzerland, France, United Kingdom, Denmark
-
IRCCS Policlinico S. MatteoRecruitingAL AmyloidosisGermany, Italy, Spain, Switzerland, Netherlands
-
Mundipharma Research LimitedActive, not recruitingMultiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell LymphomaFrance, United States, Netherlands, Spain, Switzerland, Germany, Italy
-
UNICANCERCompletedLung CancerFrance, Switzerland, United Kingdom
-
Swiss Group for Clinical Cancer ResearchEuropean Mantle Cell Lymphoma NetworkTerminatedMantle Cell LymphomaItaly, Germany, Switzerland
-
Immatics Biotechnologies GmbHBioNTech SE; University Hospital Tuebingen; BCN Peptides; EU-funded GAPVAC ConsortiumCompletedGlioblastomaSpain, Switzerland, Denmark, Germany, Netherlands
-
European Organisation for Research and Treatment...UnknownBrain and Central Nervous System TumorsSwitzerland, France
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingRenal Cell CarcinomaSwitzerland
-
ETOP IBCSG Partners FoundationUSZ FoundationRecruitingMelanoma | Non-Small Cell Lung CancerSwitzerland, Netherlands, Italy, United Kingdom
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Neoplasms | Non-Small-Cell Lung Carcinoma | Other Solid TumorsSpain, Germany, Singapore, Switzerland, Japan, United States
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell Lung | Carcinoma, Small CellUnited Kingdom, Czechia, Germany, Poland, Spain, Switzerland
-
PfizerCompletedMelanoma | Unresectable Metatstatic Cutaneous MelanomaSwitzerland, Germany, France
-
Swiss Group for Clinical Cancer ResearchCompletedLymphomaFrance, Switzerland, Italy
-
European Organisation for Research and Treatment...CompletedLymphomaGermany, Switzerland, Israel, United Kingdom, Austria, Italy
-
Johnny MoonsCompletedNon Small Cell Lung CancerBelgium, Germany, France, Spain, Switzerland, Turkey
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
European Organisation for Research and Treatment...RecruitingOropharyngeal Cancer | Hypopharyngeal Squamous Cell Carcinoma | Supraglottic Squamous Cell CarcinomaSpain, Belgium, Switzerland, Italy, United Kingdom, Germany, France, Poland
-
Clinuvel Pharmaceuticals LimitedUnknownCarcinoma, Squamous Cell | Actinic Keratoses | Organ Transplant RecipientsAustralia, Sweden, Switzerland, Italy, France, Belgium, Germany
-
European Organisation for Research and Treatment...CompletedTesticular Germ Cell Tumor | Unspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
EMD SeronoCompletedColorectal Cancer | Ovarian Cancer | Prostate Cancer | Carcinoma, Non-small-cell LungUnited States, Switzerland
-
Nerviano Medical SciencesRecruitingGlioblastoma | Diffuse GliomaSwitzerland, United States, Netherlands, Italy
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
Niguarda HospitalActive, not recruitingCLL TransformationItaly, Switzerland
-
Assistance Publique - Hôpitaux de ParisRecruitingInitial Radiological Diagnosis Eligible for Tumor Resection | Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type) | Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant TemozolomideBelgium, France, Switzerland
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerSpain, France, Belgium, Israel, Switzerland, Netherlands, Italy